Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)
2015; Elsevier BV; Volume: 26; Issue: 4 Linguagem: Inglês
10.1093/annonc/mdv011
ISSN1569-8041
AutoresDieter Koeberle, Daniel Betticher, Roger von Moos, D. Dietrich, Peter Brauchli, Daniela Baertschi, K Matter, Sun Young Rha, Markus Borner, Sandro Anchisi, Peter Moosmann, Attila Kollár, Piercarlo Saletti, A. Roth, M. Frueh, Marc Kueng, Răzvan Popescu, S. Schacher, Viviane Hess, Richard Herrmann,
Tópico(s)Hepatocellular Carcinoma Treatment and Prognosis
Referência(s)